| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.37B | 38.94B | 38.18B | 33.10B | 30.50B | 28.45B |
| Gross Profit | 6.89B | 7.00B | 6.96B | 6.47B | 5.87B | 5.73B |
| EBITDA | 2.81B | 2.93B | 2.97B | 2.39B | 2.22B | 2.33B |
| Net Income | 1.24B | 1.27B | 1.27B | 930.89M | 883.50M | 975.88M |
Balance Sheet | ||||||
| Total Assets | 18.79B | 22.24B | 19.38B | 19.88B | 15.63B | 15.26B |
| Cash, Cash Equivalents and Short-Term Investments | 1.14B | 728.90M | 1.16B | 840.81M | 758.87M | 776.21M |
| Total Debt | 1.09B | 2.48B | 1.43B | 3.32B | 1.51B | 2.30B |
| Total Liabilities | 7.87B | 10.16B | 8.63B | 10.36B | 7.06B | 7.55B |
| Stockholders Equity | 10.58B | 11.72B | 10.42B | 9.21B | 8.28B | 7.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.30B | 2.21B | -1.59B | 876.16M | 322.79M |
| Operating Cash Flow | 0.00 | 2.25B | 5.66B | 1.14B | 3.19B | 1.78B |
| Investing Cash Flow | 0.00 | -3.58B | -3.34B | -2.75B | -2.27B | -1.49B |
| Financing Cash Flow | 0.00 | 891.00M | -2.00B | 1.70B | -923.10M | -500.68M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥811.01B | 19.74 | 19.13% | 2.64% | 9.45% | 12.93% | |
71 Outperform | ¥9.20B | 7.25 | ― | 1.59% | 1.98% | -0.51% | |
64 Neutral | ¥135.95B | 11.41 | ― | 2.82% | 13.31% | -11.40% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥52.52B | 11.80 | ― | 4.49% | 10.55% | -5.43% | |
53 Neutral | ¥274.97B | 17.73 | ― | 1.24% | 19.04% | 108.13% | |
49 Neutral | ¥3.43B | 21.74 | ― | 1.08% | -0.94% | ― |